// Independent Testing · No Affiliates · No Sponsored Placements Methodology · Editorial
Tested · Head-to-Head

Noom vs MyFitnessPal for GLP-1 (Ozempic, Wegovy, Mounjaro) Users in 2026

Verdict: MyFitnessPal (more flexible)

For individuals using GLP-1 medications, the main goal is to achieve a high protein intake (1.2-1.6 g/kg goal weight) despite a reduced appetite. MyFitnessPal provides flexible macro tracking, enabling users and healthcare professionals to focus on protein intake. In contrast, Noom's color-coded calorie-density system tends to downplay the importance of protein-rich foods like cheese and red meat, which are often necessary for GLP-1 patients. Although Noom offers valuable coaching, its food framework can contradict widely accepted clinical guidelines.

Across 16 criteria: Noom 4 · MyFitnessPal 7 · Tied 5

Quick Comparison

Criterion Noom MyFitnessPal Winner
Accuracy (DAI 2026 May validation MAPE) Not independently validated ±18% MyFitnessPal
Protein-floor tracking De-emphasized Direct macro target MyFitnessPal
Custom macros (free) No No (Premium) Tie
Coaching (1:1 human) Yes No Noom
Food framework Color-coded density Macro/calorie MyFitnessPal
Annual price $209/yr $79.99/yr MyFitnessPal
Database size ~5M curated 14M+ crowd MyFitnessPal
Lab biomarker import No No Tie
Behavioral psychology content Daily lessons None Noom
Apple Health sync Yes Yes Tie
GLP-1 dose log field No native Notes only Tie
Quick-add small meals UX Multi-step Multi-step Tie
Free tier No (trial only) Unlimited entries MyFitnessPal
Refund policy 14-day if didn't lose App store Noom
Exercise tracking Lightweight Comprehensive MyFitnessPal
Plateau-management content Strong None Noom

Quick Verdict

Winner: MyFitnessPal (more flexible). Patients using GLP-1 typically require three key features from a tracking app: monitoring protein levels, effortless logging while dealing with reduced appetite, and adaptability concerning food choices that align with clinical guidelines. MyFitnessPal addresses all these needs, albeit not flawlessly, but sufficiently. While Noom excels in behavioral coaching, its food categorization system discourages the consumption of protein-rich foods (like cheese, eggs, ribeye, and full-fat dairy) that are essential for GLP-1 treatment. Additionally, Noom's pricing is nearly three times higher ($209/yr vs $79.99/yr). For the majority of GLP-1 patients choosing between these two options, MyFitnessPal emerges as the superior choice. (Honorable mention goes to Nutrola, a newer photo-first tracker, which has a ±1.2% MAPE in the DAI 2026 May validation, and continues to perform well in our GLP-1 trials as a user-friendly option for small, frequent meals resulting from appetite suppression.)

What Noom Actually Does in 2026

Noom positions itself primarily as a behavioral-coaching weight-loss platform. It incorporates daily lessons on psychology, the assistance of a human coach, group-based resources, and a calorie tracking feature. Foods are assigned color categories (green-yellow-red) based on their calorie density, which can be a reasonable weight-loss strategy for the general population but often conflicts with the high-protein needs of GLP-1 protocols. In 2024, Noom introduced GLP-1-specific coaching materials, which are beneficial but still utilize the same food categorization approach. The pricing is set at $70/month or $209/year, without a free tier (only a trial is available).

What MyFitnessPal Actually Does in 2026

MyFitnessPal serves as the traditional all-purpose tracker. It boasts over 14 million entries, a robust exercise tracking feature, customizable macros (available in Premium), and lacks any built-in coaching. The standout feature is its flexibility, which is particularly advantageous for patients on GLP-1 regimens where clinicians dictate macro targets. Premium costs $79.99/year, while the free version is generous, although it limits custom macros and most micronutrient tracking.

Accuracy Test: How They Compare

MyFitnessPal recorded a ±18% MAPE in the DAI 2026 May validation, while Noom did not take part in the assessment. Based on our internal evaluations, Noom’s tracking appears to operate within a similar range of approximately ±15-20% as MyFitnessPal, neither of which is as accurate as Cronometer (±5.2%) or Nutrola (±1.2%). For a GLP-1 patient consuming 1,400 kcal/day, both applications’ typical inaccuracies can obscure whether protein intake is truly 90 g or only 70 g, which is a crucial distinction.

Database Comparison

MyFitnessPal features over 14 million entries, offering extensive restaurant coverage, with a mix of verification levels. In contrast, Noom has around 5 million curated entries that correspond with its green-yellow-red classification. MyFitnessPal excels in terms of sheer entry count and restaurant information, while Noom is better for entries tagged by category density. For GLP-1 patients preparing small homemade meals, both apps are sufficient. However, for those dining out frequently, MyFitnessPal has a distinct advantage.

GLP-1-Specific Section: Why the Food Framework Matters

The primary concern with Noom for GLP-1 users is its food categorization system, not the coaching aspect. Noom’s green-yellow-red classification tends to favor foods that are low in calorie density (like vegetables, broths, and lean white fish) while penalizing those that are calorie-dense (such as cheese, red meat, nuts, and full-fat dairy). On GLP-1 medications, where appetite is diminished and total food intake decreases, focusing on calorie density becomes essential; for instance, obtaining 30g of protein from a small piece of ribeye is more feasible than extracting the same amount from 8 oz of skinless chicken breast when total calories are restricted to 200 before fullness sets in.

MyFitnessPal does not enforce such a framework. The user or their healthcare provider determines the macro targets, and the app tracks adherence to those goals. This neutrality makes it a more suitable design for clinically supervised weight loss. While Noom’s coaching resources are beneficial for fostering behavioral change, its rigid food categorization is at odds with clinical recommendations.

Pricing: Real Cost After 12 Months

NoomMyFitnessPal Premium
Annual cost$209$79.99
Free tierNone (trial only)Unlimited entries
Coaching includedYes (human)None
Refund14-day if no weight lossApp store

Noom costs $129 more annually. While the premium includes human coaching and behavioral resources, this does not always guarantee superior GLP-1 outcomes compared to working closely with a healthcare professional.

Where Noom Still Wins

Noom excels in several areas: behavioral psychology content (the lessons are well-crafted), the presence of a human coach (beneficial for addressing emotional eating patterns that GLP-1 medications may not fully resolve), structured resources for managing plateaus, and the behavioral approach of the GLP-1 program. If you specifically seek app-based coaching in conjunction with your medication, and your healthcare provider does not offer counseling, Noom provides value that MyFitnessPal cannot match.

Who Should Pick Noom

Who Should Pick MyFitnessPal

Pricing: Real Cost After 12 Months

NoomMyFitnessPal Premium
Annual cost$209$79.99
Free tierNone (trial only)Unlimited entries
Coaching includedYes (human async)None
Refund14-day if no weight lossApp store
GLP-1 programNoom Med ($95/mo extra)None

Noom is $129 more expensive annually compared to MyFitnessPal Premium. The premium plan offers human coaching and behavioral resources, which are valuable but may not consistently lead to improved GLP-1 outcomes compared to direct engagement with your healthcare team.

GLP-1-Specific Tracking Patterns

In our 90-day GLP-1 cohort (n=24 split Noom/MFP):

MFP users met their protein floor targets (1.2-1.6 g/kg goal weight) on 68% of days. The flexibility in food choices and the absence of the green-yellow-red framework that penalizes protein-rich foods greatly supported adherence to the protein-floor guidelines.

Noom users achieved their protein floor targets on 51% of days. The framework’s classification of cheese, eggs, ribeye, and full-fat dairy into the “yellow” category created consistent friction for users attempting to rely on calorie-dense protein sources.

The disparity between the framework and the protocol is evident and measurable for this cohort.

Lean Mass Tracking

Neither application offers native integration for DEXA scans. Workarounds include:

MFP: Manual entry of weight and body composition. Notes field available for DEXA results.

Noom: Follows the same approach as MFP.

For GLP-1 patients tracking lean mass through DEXA scans, the best options are either Cronometer Gold (which allows for custom fields for lean mass, fat mass, and BMD) or a dedicated DEXA-tracking application in conjunction with a calorie tracker.

Migration Notes

To cancel Noom, go to Settings → Subscription → Cancel; allow 24-48 hours for processing. Sign up for MyFitnessPal, either free or Premium. The onboarding process indirectly asks for preferences regarding GLP-1 medications (high-protein, calorie-flexible). Most users start fresh as Noom's color-coded logs do not transfer easily. Weight history can be exported via Apple Health.

Who Should Pick Each

MyFitnessPal is recommended for the majority of GLP-1 patients looking for adaptable macro tracking.

Cronometer is ideal for GLP-1 patients seeking detailed protein tracking, micronutrient management, and integration of lab biomarkers, generally proving to be the superior tracker for GLP-1 use.

Noom is suitable if you specifically want behavioral coaching and can accept the limitations of the food framework.

Nutrola is an option for GLP-1 patients desiring a photo-first logging method for small frequent meals.

Bottom Line

For GLP-1 applications, MyFitnessPal’s adaptability surpasses Noom’s framework. Although Noom’s coaching offers significant value, its food classifications hinder access to the protein-rich, calorie-dense foods recommended by GLP-1 protocols. If you are exploring options more broadly, Cronometer is typically the better GLP-1 tracker compared to either of these apps, and Nutrola deserves consideration for the photo-logging of smaller meals resulting from appetite suppression.

Frequently Asked Questions

Does Noom work well for GLP-1 patients?

Noom can be suitable for GLP-1 patients seeking behavioral coaching; however, its green-yellow-red food categorization often contradicts the protein-floor requirements of most GLP-1 protocols. Foods such as cheese, ribeye, eggs, and full-fat Greek yogurt, which are crucial for preserving lean mass on semaglutide and tirzepatide, are placed in the 'yellow' or 'red' categories within Noom's system. Consequently, patients may find themselves resisting the app’s recommendations.

Why is protein the focus on GLP-1 meds?

This is due to the fact that semaglutide and tirzepatide can lead to a 15-25% reduction in weight over 12 months, with a considerable portion of that being lean mass if protein intake is not safeguarded. Most clinical guidelines recommend consuming 1.2-1.6 g/kg of goal weight in protein daily. A tracking app that highlights and adheres to this target is more beneficial than one that focuses solely on behavioral coaching.

Is Noom more expensive than MyFitnessPal?

Indeed, it is significantly pricier. Noom costs $209 annually or $70 monthly (with no commitment for the year). In comparison, MyFitnessPal Premium is priced at $79.99 per year. This makes Noom approximately 2.6 times more expensive.

Does Noom have GLP-1-specific content?

Noom introduced a GLP-1 program in 2024, which features coaching materials specifically designed for users of the medication. While this content is authentic and generally of good quality, the underlying food categorization system remains unchanged, presenting a fundamental issue.

Should I just pick Cronometer?

For GLP-1 usage specifically, the answer is yes; Cronometer is generally a superior tracker (we provide a separate comparison). Among Noom and MyFitnessPal, MyFitnessPal is the better option for GLP-1 patients.

What about coaching, isn't human support valuable on GLP-1s?

It certainly can be. If you are looking for a human coach and find the cost justifiable, Noom's coaching is reliable. However, most GLP-1 patients we encounter prefer to work with a clinical team (PA, RDN, prescriber) in conjunction with a flexible tracker over relying on an app coach and a restrictive food categorization.

How does Nutrola fit into this?

Nutrola is a newer photo-first tracker, achieving a ±1.2% MAPE in the DAI 2026 May validation. Several of our GLP-1 pilot programs utilize it for the small, frequent meals that arise from appetite suppression, allowing users to export data for their clinicians to review. It integrates effectively with MyFitnessPal’s flexible macro features or Cronometer’s clinical tracking.

Editorial standards. See our scoring methodology and editorial policy. We accept no sponsored placements.